Amaryllis Therapeutics, Inc. — Form D
Amaryllis Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-18. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Other.
Offering
- Filed: 2024-09-18
- Form: D
- Accession: 0002037518-24-000003
- Industry: Other
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.5M
- Investors: 1
- Date of first sale: 2024-09-10
- Revenue range: Decline to Disclose
- SEC file number: 021-524377
Issuer
- Name: Amaryllis Therapeutics, Inc.
- CIK: 0002037518
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 700 MAIN STREET, CAMBRIDGE, MA, 02139
- Phone: 617-863-3650
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Jeongseuk Kang | Director | CAMBRIDGE, MA |
| Emmanouil Karagiannis | Director | CAMBRIDGE, MA |
| Jeongseuk Kang | Executive Officer | CAMBRIDGE, MA |
More